Fresenius Kabi Pharmaceuticals (APCVZ)

[The Rainmaker]

That's the total market for Bicalutamide also known as Casodex. Astra Zeneca sells it, several others have approval to sell generic versions. What percentage of the total market will Fresenius Kabi Pharmaceuticals garner and how long will it take?

FDA Approves Generic Casodex (Bicalutamide) for Prostate Cancer

India-based drug maker Sun Pharmaceuticals Industries Ltd said today it has been given U.S. Food and Drug Administration approval to market generic versions of the prostate cancer drug Casodex.

Casodex, known generically as bicalutamide, is made by AstraZeneca PLC and is administered in tablet form. Casodex earned annual sales of about $314 million in the United States, officials said.

http://www.attorneyatlaw.com/2009/07/fda-approves-generic-casodex-bicalutamide-for-prostate-cancer/